Second Sight Medical Products (EYES) Short Interest Ratio & Short Volume

Short interest is the volume of Second Sight Medical Products shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 361,000 shares of EYES short. Learn More on Second Sight Medical Products' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EYES shares currently have a short interest ratio of 4.0. Learn More on Second Sight Medical Products's short interest ratio.

Second Sight Medical Products saw a decrease in short interest during the month of August. As of August 15th, there was short interest totaling 361,000 shares, a decrease of 68.1% from the previous total of 1,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Second Sight Medical Products: Electromed, Inc. (2.26%), QT Imaging Holdings, Inc. (1.89%), NeurAxis, Inc. (0.52%), Cutera, Inc. (19.35%), ViewRay, Inc. (0.18%), Viveve Medical, Inc. (0.03%), ProQR Therapeutics N.V. (0.67%), Sight Sciences, Inc. (4.26%), Neurogene Inc. (19.15%), OmniAb, Inc. (8.23%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power, Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks.

Short selling EYES is an investing strategy that aims to generate trading profit from Second Sight Medical Products as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Second Sight Medical Products occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EYES, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EYES, twice per month. The most recent reporting period available is August, 15 2022.